IPC
ANIK icon

Independent Portfolio Consultants’s Anika Therapeutics ANIK Stock Holding History

Independent Portfolio Consultants’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-250
Closed -$8K – 786
2015
Q2 		$8K Sell
250
-2,410
-91% -$86K ﹤0.01% 783
2015
Q1 		$110K Buy
2,660
+195
+8% +$7.88K 0.02% 465
2014
Q4 		$100K Sell
2,465
-8,945
-78% -$350K 0.02% 504
2014
Q3 		$418K Sell
11,410
-255
-2% -$11K 0.11% 277
2014
Q2 		$540K Buy
11,665
+530
+5% +$23.6K 0.15% 212
2014
Q1 		$457K Buy
11,135
+195
+2% +$7.25K 0.14% 256
2013
Q4 		$417K Buy
+10,940
New +$338K 0.15% 293

Other funds holding ANIK

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
LCP
Lombardia Capital Partners Pasadena, California $110M AUM 13.11% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

Independent Portfolio Consultants's ANIK Position: Q3 2015 in Review

Independent Portfolio Consultants sold out of Anika Therapeutics (ANIK) in Q3 2015, closing a stake of 250 shares — an estimated $8K sold.

Independent Portfolio Consultants first reported a position in ANIK in Q4 2013 and held it in 7 quarters. The position peaked at $540K in Q2 2014. 138 funds tracked by Wall St. Rank hold ANIK as of Q3 2015.

  • Independent Portfolio Consultants reported no remaining Anika Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Independent Portfolio Consultants sold 250 Anika Therapeutics shares in Q3 2015, an estimated $8K.
  • Independent Portfolio Consultants first reported a position in Anika Therapeutics in Q4 2013 and held it in 7 quarters.
  • Independent Portfolio Consultants's Anika Therapeutics position peaked at $540K in Q2 2014.
  • 138 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2015.

Based on Independent Portfolio Consultants's 13F filing for Q3 2015, filed 19 Oct 2015.